Quarterly report pursuant to Section 13 or 15(d) 09-30-2018

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Product revenue
Costs of revenue
Gross profit
Operating expenses:        
Research and development 549 1,023 1,979 2,624
General and administrative 654 901 3,316 2,742
Sales and marketing 50 42 204
Goodwill impairment 6,162 6,162
Total operating expenses 7,365 1,974 11,499 5,570
Loss from operations (7,365) (1,974) (11,499) (5,570)
Other income (expenses):        
Interest expense (83) (270) (1,367) (1,008)
Loss on extinguishment of derivative liabilities (1,252)
Offering costs (682) (131)
Loss on extinguishment of debt (340)
Change in fair value of derivative liabilities 4,480 756 6,500 2,938
Other income (loss), net 1 1 6 (2)
Total other income, net 4,398 487 2,865 1,797
Net loss before income taxes (2,967) (1,487) (8,634) (3,773)
Provision for income taxes
Loss from continuing operations (2,967) (1,487) (8,634) (3,773)
Loss from discontinued operations (280) (582) (324) (511)
Net loss (3,247) (2,069) (8,958) (4,284)
Deemed dividend related to the beneficial conversion feature and accretion of a discount on Series B preferred stock (7,641) (14,975)
Net loss attributable to common stockholders $ (10,888) $ (2,069) $ (23,933) $ (4,284)
Net loss per share        
Basic and diluted - continuing operations $ (0.24) $ (0.49) $ (1.18) $ (1.29)
Basic and diluted - discontinued operations (0.02) (0.19) (0.04) (0.18)
Basic and diluted - deemed dividend and accretion of a discount on conversion of Series B preferred stock (0.61) (2.05)
Basic and diluted - attributable to common stockholders $ (0.87) $ (0.68) $ (3.28) $ (1.47)
Weighted average common shares outstanding:        
Basic and diluted 12,559,129 3,022,073 7,306,295 2,918,240